Prolight Diagnostics
17.80 SEK
+1.83 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Prolight Diagnostics
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| growth-% | ||||||
| EBITDA | -5.0 | -7.1 | -8.8 | -27.4 | -25.8 | -33.6 |
| EBIT | -5.0 | -7.1 | -8.9 | -28.1 | -27.3 | -53.2 |
| Profit before taxes | -4.3 | -6.9 | -2.8 | -27.8 | -26.9 | -53.1 |
| Net income | -4.3 | -6.9 | -2.8 | -27.8 | -26.9 | -49.7 |
| EPS | -2.91 | -4.20 | - | -9.15 | -3.66 | -4.13 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| EBITDA-% | ||||||
| EBIT-% | ||||||
| ROE | -2.8 % | -4.7 % | -1.4 % | -11.5 % | -21.0 % | -29.4 % |
| ROI | -2.8 % | -4.6 % | -1.4 % | -10.0 % | -16.2 % | -25.7 % |